| 查看: 595 | 回复: 1 | |||
jinqingxian至尊木虫 (著名写手)
有机脑力学-合成手艺学
|
[交流]
安帕来斯
|
| 谁知道安帕来斯的情况,是否允许上市?国内还是国外?销售和疗效情况如何? |
» 猜你喜欢
各位大佬,H口面上什么时候会评???
已经有30人回复
谁有人卫版 《毒理学基础》第七版书籍
已经有0人回复
药物学论文润色/翻译怎么收费?
已经有68人回复
26有没有老师想收做定量药理的学生啊
已经有3人回复
26考博申请 学or专
已经有15人回复
2026年山东大学海洋学院生物与医药博士招生-李霞课题组
已经有0人回复
博士研究生招生
已经有0人回复
药理学、临床药学方向 调剂
已经有1人回复
广西医科大学基础医学院自身免疫病课题组招收基础医学相关专业的调剂研究生
已经有2人回复

thecoldest
金虫 (正式写手)
- 应助: 148 (高中生)
- 金币: 1772.7
- 散金: 30
- 红花: 33
- 帖子: 588
- 在线: 116.3小时
- 虫号: 1119567
- 注册: 2010-10-11
- 专业: 药物分析
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
小木虫: 金币+0.5, 给个红包,谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
|
应该是因临床试验效果不好,被原研制方Cortex放弃了 http://www.trademarkia.com/ampakine-77965906.html ABANDONED - NO STATEMENT OF USE FILED 11/5/2012 https://en.wikipedia.org/wiki/CX-516 CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD. CX-516 was the first ampakine compound developed by Cortex and while it showed good in vitro activity and positive results in animal tests, the human trials proved disappointing due mainly to low potency and short half-life. However, CX-516 is still widely used in animal research into the ampakine drugs and is the standard reference compound that newer, more potent drugs of this class such as farampator and CX-717 are compared to. |

2楼2016-01-03 09:48:42














回复此楼